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Abstract The Madin-Darby canine kidney (MDCK) cell
line expresses many characteristics of the renal collect-
ing duct. The MDCK-C7 subclone forms a high-resis-
tance, hormone-responsive model of the principal cells,
which are found in distal sections of the renal tubule.
The electrophysiological technique of short-circuit cur-
rent measurement was used to examine the response to
antidiuretic hormone (ADH) in the MDCK-C7 clone.
Three discrete electrogenic ion transport phenomena can
be distinguished temporally and by the use of inhibitors
and effectors. Initially the cells exhibit anion secretion
through the cystic fibrosis transmembrane conductance
regulator (CFTR). The presence of CFTR was confirmed
by immunoprecipitation followed by Western blotting.
The CFTR-mediated anion secretion is transient and is
followed, in time, by a verapamil- and Ba2+-sensitive an-
ion secretion or cation absorption and, finally, by Na+ re-
absorption via epithelial Na+ channels (ENaC). In con-
trast to other studies of MDCK cells, we see no indica-
tion that the presence of CFTR functionally inhibits
ENaC. The characterization of the various ion transport
phenomena substantiates this cell line as a model renal
epithelium that can be used to study the hormonal and
metabolic regulation of ion transport.
Key words Amiloride · Cystic fibrosis transmembrane
regulator · Electrogenic transport · Epithelial sodium
channel · Potassium channels · Principal cells · Renal
epithelia · Verapamil
Introduction
The Madin-Darby canine kidney (MDCK) cell line has
been widely used as a model for the study of vectorial
protein sorting in polarized epithelial cells and, more re-
cently, as a transfection model for protein expression.
This cell line has many of the characteristics of the epi-
thelial cells lining the distal portion of the renal nephron
[22, 32] but the parent line shows cellular heterogeneity
and several laboratories have produced subclones with
various characteristics [9, 15, 16, 19, 21, 22, 32, 34]. The
laboratory of Dr. H. Oberleithner has isolated two sub-
clones. The C7 line has many of the characteristics of the
principal cells while the C11 subclone demonstrates
characteristics of intercalated cells [9].
The MDCK-C7 cells form a monolayer in culture
which develops a high-resistance (>1000 W cm2) pheno-
type. We have characterized the natriferic responses of
this epithelium to aldosterone, insulin-like growth factor
1 (IGF1) and antidiuretic hormone (ADH) in cells grown
on permeable supports, and found that confluent mono-
layers have hormone-mediated Na+ transport responses
that are similar to those described for the mammalian
distal nephron [2].
In subsequent studies using the C7 subclone to dissect
the signal transduction pathways involved in hormonal
stimulation, it became apparent that these cells have
multiple electrogenic transport processes. This is consis-
tent with the expectation of transport phenomena in the
mammalian distal tubule and distinguishes this cell line
from the amphibian models of principal cells, such as the
A6 cell line and the toad urinary bladder. The complex
nature of the transport processes in MDCK-C7 cells
makes them a more applicable model in which to study
reported interactions between transporters in response to
a single stimulus.
Since there is a lack of well-characterized distal tu-
bule cell lines, many previous studies have utilized trans-
fection techniques, where the transport proteins of inter-
est have been overexpressed and/or expressed in heterol-
ogous cells. In either case, the normal regulatory compo-
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nents of the transport process may be ineffective. To
characterize a model system which endogenously ex-
presses several transporters, we have examined, in detail,
the cellular response to ADH in the MDCK-C7 cell line.
We determined that there are least three distinct electro-




The hormones and inhibitors used in these experiments were:
ADH ([arg]-vasopressin, Sigma, St. Louis, Mo., USA); amiloride
hydrochloride (Sigma); DASU-01 (synthesized and donated by Dr.
R. Bridges, University of Pittsburgh, Pa., USA); 5-nitro-2-(3-phe-
nylpropylamino)-benzoic acid (NPPB; Biomol Research, Plym-
outh Meeting, Pa., USA); barium chloride (BaCl2; Sigma); and
verapamil hydrochloride (ICN Biomedical, Aurora, OH, USA).
The antibodies used for immunoprecipitation and Western blotting
were monoclonal mouse anti-human cystic fibrosis transmem-
brane conductance regulator (CFTR), R-domain-specific (Gen-
zyme, Cambridge, Mass., USA) and peroxidase-conjugated goat
IgG fraction to mouse IgG (Cappel Research, Durham, N.C.,
USA). Other supplies used in the immunoprecipitation were
GammaBind Plus Sepharose (LKB Biotechnology, Uppsala,
Sweden) and chemiluminescent detection reagents (Chemilum,
New England Nuclear, Life Sciences, Boston, Mass., USA).
MDCK-C7 cell culture
The MDCK-C7 cells were grown in a 37°C humidified incubator
with a 5% CO2 and 95% O2 gas mixture. Initially the cells were
grown in 75 cm2 flasks and fed with Minimal Media with Earle’s
salts, non-essential amino acids and L-glutamine (MEM;
Gibco/BRL, Grand Island, New York, USA) supplemented with
10% fetal bovine serum (Sigma), 26 mM NaHCO3 and adjusted to
pH 7.0. The confluent cells were subcultured by trypsinization and
the cells were seeded (5.4 · 104 cell/cm2) onto Nucleopore polycar-
bonate membranes forming the bottom of Transwell chambers
(Costar, Cambridge, Mass., USA). The Transwell chambers were
placed in specially designed tissue culture plates to form a two-
compartment system in which media are added to both apical and
basolateral surfaces. The media were aspirated and replaced three
times per week. The cells were used between passages 73 and 96.
Electrophysiological studies
Nucleopore filters (4.7 cm2) containing confluent MDCK-C7 cells
(7–12 days) were removed from the Transwell chambers and
clamped between the halves of an Ussing chamber (World Preci-
sion Instruments, Sarasota, Fla., USA). Each half of the chamber
contained a tapered fluid compartment with openings for voltage
electrodes (close to the epithelial membrane) and current elec-
trodes (at the opposite end of the chamber). The fluid chamber
was water jacketed to maintain constant temperature (37°C). The
cells were bathed in serum-free MEM. The media were circulated
in the chambers by means of a 5%CO2/O2 gas lift. The electrodes
were connected to a voltage-clamp amplifier (Current Voltage
Clamp; World Precision Instruments) for measurement of net ion
flux as monitored under short-circuit conditions (SCC; short cir-
cuit current) [31]. Transepithelial resistance was calculated by ap-
plying a 2-mV pulse across the epithelium and measuring the re-
sultant deflection in SCC. Data from cultures were used only if
they maintained a resistance >1000 W cm2.
The cultures were placed in the Ussing chambers and incubat-
ed under short-circuited conditions until a steady baseline trans-
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port was achieved (0.5–1 h). The cultures were preincubated with
inhibitors, where appropriate, for 30 min prior to the addition of
ADH. ADH was added to the serosal bathing media; amiloride
was added to the apical media 30 min after ADH to determine the
portion of the transport due to flux through the amiloride-sensitive
Na+ channel. The concentrations of effectors used were: ADH,
0.1 IU/ml; amiloride, 30 µM; NPPB, 500 µM; DASU-01, 500 µM;
BaCl2, 3 mM; and verapamil, 25 µM. Each experiment was per-
formed using matched cultures grown in parallel. The data are pre-
sented as means ±SE with n indicating the number of different ex-
periments. Comparisons were performed using Student’s one-
tailed t-test for paired samples; values of P<0.05 were considered
significant.
CFTR immunoprecipitation and Western blotting
To prepare total cell extracts for identification of CFTR, the
MDCK-C7 cells were scraped from the Transwell supports using
serum-free medium, pelleted and washed once by centrifugation
at 1200 g. The cell pellet was homogenized in homogenizing
Fig. 1A,B Ion transport response of MDCK-C7 cells to stimula-
tion by [arg]-vasopressin (ADH). Ion transport is measured as
short-circuit current (SCC). A positive deflection indicates cation
movement from the apical to serosal bathing medium or anion
movement from serosal to apical medium. Where indicated, ADH
(100 mU/ml) was added to the serosal bathing medium at time
zero. After 30 min, amiloride (10–5 M) was added to the apical so-
lution. A The entire 30-min time course of the experiment as well
as 10 min of the stabilization period (–10–0 min) and the 10 min
after the addition of amiloride (30–40 min). B The same data but
only showing the first 10 min of the ADH response with additional
time points to better illustrate the multiphasic nature of the re-
sponse. Symbols denote the mean ±SEM. n=number of paired ex-
periments. Between 4 and 30 min the means of the ADH-treated
samples were significantly different from control samples (P<0.05)
612
buffer (50 mM TRIS/1% Triton X-100, pH 7.5) using 40 strokes
of a Dounce tight-fitting homogenizer. The homogenate was spun
in a microfuge (16,000 g) and the supernatant containing the sol-
ubilized proteins was incubated with mouse anti-CFTR antibody
(1:1000 dilution) for 1 h at room temperature. GammaBind Plus
Sepharose beads were added to bind the antigen/antibody com-
plexes and the incubation was continued on a rotary stirrer for 2 h
at room temperature. The beads were pelleted (16,000 g) and
washed five times with wash buffer (0.3% NP-40, 0.3% sodium
deoxycholate, 0.3% NaCl, 50 mM TRIS, pH 7.4) with 5-min in-
cubations on the rotary stirrer between washes. The wash buffer
washes were followed by three washes with deionized water. Af-
ter the final wash, the pelleted beads were extracted by a 30-min
incubation with sodium dodecyl sulfate (SDS) lysis buffer
(50 mM TRIS, pH 6.8, 2% SDS, 120 mM dithiothreitol, 10%
glycerol). The 16,000 g supernatant from the extraction was sepa-
rated by one-dimensional polyacrylamide gel electrophoresis
(1D-PAGE) using a 7.5% separatory gel and 4% stacking gel. Af-
ter electrophoresis, the separated proteins were electrophoretical-
ly transferred to PVDF (polyvinylidene fluoride) blotting mem-
branes.
The PVDF-immobilized protein blots were blocked with 1%
bovine serum albumin to prevent non-specific binding and probed
using a CFTR antibody (monoclonal mouse anti-human CFTR R-
domain specific) followed by binding of a secondary horseradish
peroxidase IgG (goat anti-mouse). The specific binding was de-
tected using a chemiluminescent detection method (Chemilum)
according to the manufacturer’s instructions.
Results
ADH has been previously shown to stimulate an increase
in amiloride-sensitive Na+flux in the MDCK-C7 sub-
clone measured both 60 and 120 min after the addition of
the hormone [2]. However, stimulation by the peptide
hormone (100 mU/ml) also leads to an immediate ion
transport response, with a rapid transient peak that oc-
curs in the first minute. This is followed by an apparent
second peak that reaches a transport maximum approxi-
mately 6 min after the addition of hormone and then de-
clines. Finally, when compared to control, there is a sus-
tained, low level of increased transport (Figure 1). In a
limited number of experiments, stimulation by 1 mU/ml
ADH produced similar results (data not shown).
Our previous data [2] suggested that the sustained ac-
tion of ADH was due entirely to Na+ absorption through
the amiloride-sensitive epithelial Na+ channel, ENaC. To
determine whether the more rapid transport events are
also mediated via the Na+ transport pathway, cells were
pretreated with amiloride for 10 min before the addition
of ADH (Fig. 2). Interestingly, amiloride appeared to
block only the sustained transport seen at the later time
points and had no effect on the first two transport peaks.
Thus, it appears that ADH stimulates several transport
events in the MDCK-C7 cells.
Fig. 2A,B Ion transport response of MDCK-C7 cells to stimula-
tion by ADH in control and amiloride-pretreated cells. Ion trans-
port is measured as short circuit current (SCC). A positive deflec-
tion indicates cation movement from the apical to serosal bathing
medium or anion movement from serosal to apical medium.
Where indicated, amiloride was added to the apical medium at
–10 min. After a 10-min preincubation, ADH (100 mU/ml) was
added to the serosal bathing medium at time zero. After 30 min,
amiloride (10–5 M) was added to the apical solutions. A The entire
time course of the experiment. B The same data but only showing
the first 10 min of the ADH response with additional time points.
Symbols denote the mean ±SEM. n=number of paired experi-
ments. The means of the amiloride-treated samples were signifi-
cantly different from control samples (*P<0.05) at the time points
indicated in A
Fig. 3 Ion transport response of MDCK-C7 cells to stimulation by
genistein in control and amiloride-pretreated cells. Ion transport is
measured as short-circuit current (SCC). A positive deflection in-
dicates cation movement from the apical to serosal bathing medi-
um or anion movement from serosal to apical medium. Where in-
dicated, amiloride was added to the apical medium at –10 min. Af-
ter a 10-min preincubation, genistein (40 µg/ml) was added bilat-
erally at time zero. After 60 min, amiloride (10–5 M) was added to
all apical solutions. Symbols denote the mean ±SEM. n=number of
paired experiments
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A possible mechanism for the initial increase in trans-
cellular transport was suggested by treatment of the cells
with genistein, an isoflavone which inhibits tyrosine kin-
ases [27]. This compound has been shown to inhibit both
insulin- and aldosterone-stimulated Na+ transport in the
A6 cell line [20]. However, genistein has also been
shown to stimulate an anion transport response via the
CFTR protein ([23] and references contained therein).
Treatment of the MDCK-C7 cells with genistein caused
an immediate increase in transport, similar to the type of
response elicited by ADH (Fig. 3). The genistein-stimu-
lated transport was not due to an increase in Na+ because
the magnitude of the response was maintained in cells
which had been pretreated with amiloride.
These findings suggested that the initial transport re-
sponse in the MDCK-C7 cells may be due to anion flux
via CFTR. To explore this possibility, we tested the ef-
Fig. 4A,B Ion transport response of MDCK-C7 cells to stimula-
tion by ADH in cells pretreated with inhibitors of cystic fibrosis
transmembrane conductance regulator (CFTR) ion flux. Ion trans-
port is measured as short-circuit current (SCC). A positive deflec-
tion indicates cation movement from the apical to serosal bathing
medium or anion movement from serosal to apical medium. Inhib-
itors (NPPB, 500 µM added apically; DASU-01, 500 µM, added
bilaterally) were added 30 min before the addition of ADH
(100 mU/ml) to the serosal bathing medium at time zero. In each
case, only the first 10 min of the responses to ADH is shown.
There was no significant difference between control and inhibitor-
pretreated cells after 2 min. Symbols denote the mean ±SEM.
n=number of paired experiments. The means of the inhibitor-pre-
treated samples were significantly different from control samples
(*P<0.05) at the time points indicated
Fig. 5 Western blot of CFTR immunopurified from MDCK-C7
cells. A whole-cell homogenate from MDCK-C7 cells was immu-
noprecipitated using an anti-CFTR antibody. The immunopurified
sample was separated using polyacrylamide gel electrophoresis
(7.5% separatory gel; 4% stacking gel), blotted onto PVDF mem-
brane, probed with anti-CFTR antibody and detected by chemilu-
minescence. The single band between 147 and 160 kDa represents
CFTR. The molecular weights of the standards run on the same
gel are indicated to the right of the figure
fects of two inhibitors of CFTR, NPPB and the diarylsul-
fonylurea DASU-01, on the response to ADH. NPPB in-
hibits several transport pathways while diarylsulfonyl-
ureas are thought to be more specific inhibitors of CFTR
[23]. Both of these compounds inhibited the rapid but
transient ion transport response that is stimulated within
the first minute after treatment with ADH, but did not
appear to affect the second transport event (which has a
maximal effect at approximately 2 min) (Fig. 4). These
data suggest that the initial, rapid response to ADH is an-
ion secretion via CFTR.
To confirm that the C7 subclone expresses the CFTR
protein, a whole-cell homogenate was immunoprecipitat-
ed with a monoclonal antibody to CFTR and the anti-
body-bound fraction was separated by 1D-PAGE, trans-
ferred to PVDF blotting membrane and probed with the
anti-CFTR antibody (Fig. 5). A single band of 147–160
kDa was visible after the Western blotting. This protein
is consistent with the molecular weight of the CFTR pro-
tein and confirms the presence of this transporter in the
MDCK cells.
Finally we sought to determine the nature of the ion
flux responsible for the amiloride-NPPB- and DASU-01-
insensitive component of the response to ADH. Vera-
pamil, an inhibitor of L-type Ca2+ channels as well as a
modulator of the inositol-1,4,5-trisphosphate receptor,
IP3R [18], inhibits this response suggesting a role for in-
creased intracellular Ca2+ (Fig. 6A). Interestingly, this
second component of the transport response is also sensi-
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tive to the addition of Ba2+ to the serosal but not apical
bathing medium, suggesting a role for a K+ channel on
the basolateral membrane (Fig. 6B). These results are
consistent with the presence of a Ca2+-activated K+ chan-
nel. 
Discussion
Much of our basic understanding of hormonal control of
salt and water transport comes from work done in am-
phibian model systems such as the toad urinary bladder,
frog skin and the A6 cell line derived from the kidney of
Xenopus laevis. This is, in part, because of a lack of
mammalian cell culture models for the hormone-respon-
sive principal cells found in the mammalian distal neph-
ron and cortical collecting duct. One common problem
in the development of such lines is a failure to develop a
“tight” or high-resistance phenotype that is found in the
epithelial cells lining this section of the tubule. This
makes measurement of transepithelial ion flux in intact
monolayers difficult if not impossible. Another common
problem that has been noted in cell lines that have been
derived from SV40 large T-antigen immortalized renal
cells is uncontrolled cell proliferation under permissive
temperatures [29]. However, the MDCK-C7 cells used in
these studies are relatively unique because the cell line
exhibits contact inhibition after forming an electrically
tight (1000–4000 W cm2) monolayer and, therefore,
forms an ideal model for studying ion fluxes.
Previous work has shown that the MDCK-C7 line ex-
presses ENaC and responds to the natriferic hormones,
aldosterone, ADH and IGF1 [2]. In the current study, we
have analyzed, in greater detail, the response to ADH
and have characterized multiple transport responses
(Fig. 1) that can be separated by time and use of inhibi-
tors.
Greater than 50% of the basal current appears to be
due to a constitutive level of Na+ reabsorption. When
amiloride is added to cells, there is an immediate drop in
SSC (Fig. 2, –10 to 0 time points). After the addition of
ADH, there is an increase in Na+ transport but this ap-
pears to be a relatively late event which is manifested af-
ter two other transport events and is the only electrogen-
ic ion flux that appears to be sustained for more than a
few minutes (Fig. 2; [2]).
The nature of the initial transport response was sug-
gested by the effect of genistein on the MDCK-C7 cells.
Genistein, a tyrosine kinase inhibitor, causes an increase
in Cl– flux in several epithelial lines by activating CFTR
[8, 12]. In our studies, genistein stimulated an increase in
ion transport (Fig. 3) which could be inhibited by NPPB
(data not shown), suggesting that genistein was also
stimulating flux through CFTR in the MDCK-C7 cells.
To substantiate the possibility that the first transport
event stimulated in response to ADH was anion secretion
through CFTR, MDCK-C7 cells were pretreated with
NPPB prior to stimulation with ADH. The NPPB com-
pletely blocked the initial transport response. At concen-
trations used in this experiment (500 µM), NPPB is not
specific for CFTR and has been shown to effectively in-
hibit transport through other Cl– channels such as the
outwardly rectifying Cl– channel (ORCC), Ca+-depen-
dent Cl– channel in airway epithelia and a volume-sensi-
tive ORCC [23].
However, a more specific inhibitor of CFTR, the dia-
rylsulfonylurea DASU-01, had exactly the same inhibi-
tory effect on the initial transport response (Fig. 4B),
suggesting that the ion flux represents anion secretion
through CFTR.
In order to determine if the MDCK-C7 cells express
CFTR, an immunoprecipitation was done using an anti-
CFTR antibody. Immunoprecipitation followed by im-
munodetection showed a single band, consistent with the
molecular weight of CFTR.
CFTR has been found in most sections of the nephron
as well as in cells derived from patients with autosomal
Fig. 6 Ion transport response of MDCK-C7 cells to stimulation by
ADH in cells pretreated with verapamil or Ba2+. Ion transport is
measured as short-circuit current (SCC). A positive deflection in-
dicates cation movement from the apical to serosal bathing medi-
um or anion movement from serosal to apical medium. Inhibitors
(verapamil, 25 µM, added bilaterally; Ba2+, 3 mM added as indi-
cated) were added 30 min before the addition of ADH
(100 mU/ml) to the serosal bathing solution at time zero. In each
case, only the first 10 min of the responses to ADH is shown.
There was no significant difference between control and inhibitor-
pretreated cells after 4 min. Symbols denote the mean ±SEM.
n=number of paired experiments. The means of the inhibitor-pre-
treated samples were significantly different from control samples
(*P<0.05) at the time points indicated
dominant polycystic kidney disease [10]. For the purpos-
es of this study, CFTR has been immunolocalized to the
apical membrane of distal nephron segments [4]. CFTR
has also been demonstrated in model renal cell lines of
the inner medullary collecting duct of the mouse (mI-
MCD-K2) [33] and CFTR mRNA has been found in the
M-1 line derived from mouse cortical collecting duct as
well as in cells from freshly isolated rabbit cortical col-
lecting duct [30]. Finally, CFTR is constitutively ex-
pressed in the apical membrane of the MDCK I cells,
which have characteristics of distal nephron cells [16].
Therefore, our demonstration of CFTR in the MDCK-C7
cells is consistent with what is known about the expres-
sion of this protein in the kidney as well as other princi-
pal cell models.
The anion that is secreted in response to activation of
CFTR is likely to be either Cl– or HCO3–. Previous work
has demonstrated that either species can be transported
by the CFTR channel in airway [7] as well as intestinal
[11, 25] epithelia. The nature of the anion flux will be
determined by the driving forces, predominately deter-
mined by transporters in the basolateral membrane [5, 7].
The MDCK-C7 cell line will provide a model system for
future exploration of the transporters and driving forces
that are likely to control the nature of the anion flux
through CFTR in renal epithelia.
Anion flux through CFTR equilibrates rapidly and
this initial transport is followed by a second response
that is insensitive to both the CFTR inhibitors and amilo-
ride. This second response is, however, inhibited by both
Ba2+ added to the serosal side or verapamil applied bilat-
erally (Fig. 6). Ba2+ is a relatively non-selective inhibitor
of K+ channels while verapamil is known to be an inhibi-
tor of L-type Ca2+ channels as well as a down-regulator
of the IP3R in the endoplasmic reticulum (ER). IP3 bind-
ing to the ER receptor causes the release of Ca+ through
the IP3 receptor-gated Ca+ channel [18]. While L-type
Ca2+ channels have not, to our knowledge, been demon-
strated in renal principal cells, the presence of IP3R in
the distal nephron has been recently reported [18].
These results suggest the presence of a Ca2+-depen-
dent K+ channel but do not define the nature of the in-
crease in Ca2+. The principal cells have been shown to
express two receptors for ADH, the V2 receptor which
causes an increase in cAMP by activating adenylate cy-
clase [13] and a V1 receptor that causes an increase in
IP3 [3].
Anion secretion via CFTR and Na+ reabsorption via
ENaC are stimulated by ADH binding to the V2 receptor
on the basolateral side of the cell, triggering the produc-
tion of cAMP by adenylate cyclase [13]. However, in the
principal cells of the collecting duct, ADH can also bind
the V1 receptor causing the production of IP3 [3]. The
resulting Ca+ release can be down-regulated by pro-
longed stimulation by ADH or verapamil [26].
There are multiple K+ channels which could contrib-
ute to the absorption of the important cation. Although
we have been unable to characterize this pathway fully,
several possibilities exist including channels which are
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directly activated by cAMP or indirectly activated by
changes in intracellular Ca2+ [5, 7]. Regulation of these
channels forms an important branch point for the control
of intracellular driving forces and can, for example,
modulate flux through apically located channels such as
CFTR [7], as well as contribute to the increased K+ rec-
lamation that is necessary during high Na+ reabsorption.
To summarize the results, we have found the follow-
ing transport responses to ADH in chronological order:
anion secretion via CFTR, verapamil-sensitive, Ba2+-
sensitive anion secretion or cation absorption and, final-
ly, Na+ absorption via ENaC. From these results we pro-
pose the potential model of the MDCK-C7 cells in Fig.
7. The figure shows two ADH receptors, V1 and V2, and
the two different pathways which could, theoretically, be
involved. The cAMP pathway is known to activate both
CFTR and ENaC while the IP3 pathway activates IP3R-3
causing the release of Ca2+ from the ER. In this model
we have included the L-type Ca2+ channel and the Ca2+-
activated Cl– channel although there is no direct evi-
dence that they are present.
Probably the most exciting aspect of these studies is
that the characterization of the ADH response in the C7
cells can give a unique view of the endogenous interac-
tions between CFTR and ENaC in a native epithelial
cell. The properties of CFTR as a Cl– channel are well
documented [6] but more recent studies have indicated
that this protein may directly regulate other channels
such as the outwardly rectifying Cl– channel [14] and
ENaC [24, 28]. In one of the key experiments demon-
strating that CFTR inhibits ENaC, a high-resistance sub-
clone of the MDCK cell line was used to co-express the
channels. MDCK cells were stably transfected with
ENaC and then transiently transfected with CFTR. The
ENaC-transfected cells respond to ADH stimulation with
Fig. 7 Hypothetical model of transporters in the MDCK-C7 cell
line. This hypothetical model illustrates transporters that may be
present in the MDCK-C7 cells to account for the data presented in
this manuscript. The left-hand side of the figure represents the api-
cal membrane, the right represents the basolateral membrane.
Rectangular shapes indicate apical membrane or endoplasmic re-
ticulum transporters. Elliptical shapes indicate basolateral mem-
brane transporters. Triangular indicate receptors in the plasma
membrane. Curved arrows indicate inhibitors of particular trans-
porters shown at their proposed site(s) of action
an increase in Na+ reabsorption while the cells transfec-
ted with both ENaC and CFTR showed no increase in
amiloride-sensitive transport in response to the same
stimulation [28]. The CFTR-mediated total inhibition of
ENaC activity was not transient and was maintained for
the length of the experiment. The authors concluded that
the presence of CFTR functionally inhibited the ability
of ENaC to transport Na+ in response to ADH [28].
Transporting epithelial cells endogenously express
very low numbers of functional ENaC and CFTR chan-
nels – typically 50–100 channels per cell [1, 16, 17]. The
electrophysiological data in our current studies show that
the number of functional channels found in the MDCK-
C7 cells falls within this range (calculations not shown –
see [1] for conversion chart). The total number of CFTR
channels that are present in cells could, however, be vari-
able. Whether the transporters measured in these studies
are inserted into the membrane in response to ADH or
are pre-existing and activated by a phosphorylation event
is unknown. Regardless of the mechanism of activation,
there is no indication that the presence of CFTR func-
tionally inhibits ENaC. Rather the two ion transporters
are both stimulated in response to ADH, albeit with dif-
ferent time courses. This discrepancy between a lack of
functional inhibition when the CFTR and ENaC are ex-
pressed at endogenous levels and the profound and com-
plete inhibition of ENaC by CFTR when both are over-
expressed in transfected MDCK cells remains unex-
plained. The major difference between the two situations
is, of course, the number of expressed channels. Previous
studies have shown that hyperexpression of CFTR alters
its regulation and physiological properties [17]. Resolu-
tion of this enigma will require additional experimenta-
tion.
The characterization of the ADH response in the non-
transfected MDCK-C7 clonal line will provide a better
understanding of the complexity of hormone effects on
the principal cells of the distal nephron. These cells will
also be a useful model with which to examine the trans-
port and metabolic effects that govern the nature of the
anion which is secreted by CFTR and the interaction of
this channel with other transporters.
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